Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5968584 | 0.90 | TSHR (0.36) | TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL25420322 | 0.89 | TSHR (0.35) | TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL27774624 | 0.88 | TSHR (0.34) | TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL28055435 | 0.88 | TSHR (0.34) | TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL28055449 | 0.88 | TSHR (0.34) | TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL27774626 | 0.88 | TSHR (0.34) | TSHRALDH1A1CYP3A4HPGD | |
| SCHEMBL2124922 | 0.83 | TSHR (0.32) | TSHRALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL2830959 | 0.83 | TSHR (0.40) | TSHRALDH1A1TP53CYP3A4HIF1A | |
| SCHEMBL28641397 | 0.81 | TSHR (0.38) | TSHRALDH1A1TP53HIF1AHPGD | |
| SCHEMBL1850147 | 0.81 | TSHR (0.32) | TSHRALDH1A1TP53CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3842417-B1 | COMPOSITION, PRODUCTION METHOD FOR COMPOSITION, AND PRODUCTION METHOD FOR UNSATURATED COMPOUND | RESONAC CORP (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-11661474-B2 | Composition, production method for composition, and production method for unsaturated compound | SHOWA DENKO K.K. (JP) | 2023-05-30 | — | — | US | disclosed |
| CN-111836867-B | Adhesive composition | 株式会社LG化学 | 2022-09-30 | — | — | CN | disclosed |
| CN-114685713-A | Polymer, electrolyte, and lithium ion battery comprising same | 财团法人工业技术研究院 | 2022-07-01 | — | — | CN | disclosed |
| CN-111433306-B | Back grinding belt | 株式会社LG化学 | 2022-05-10 | — | — | CN | disclosed |
| CN-111655811-B | Adhesive sheet for temporary attachment and method of manufacturing semiconductor device using the same | 株式会社LG化学 | 2022-04-15 | — | — | CN | disclosed |
| CN-110785469-B | Dicing die bonding film | 株式会社LG化学 | 2022-04-08 | — | — | CN | disclosed |
| CN-108886841-B | Heating element | 株式会社LG化学 | 2022-02-25 | — | — | CN | disclosed |
| CN-111225963-B | Adhesive sheet for temporary fixation and method for manufacturing semiconductor device using the same | 株式会社LG化学 | 2022-02-22 | — | — | CN | disclosed |
| EP-3533813-B1 | GEL POLYMER ELECTROLYTE, METHOD FOR PRODUCING GEL POLYMER ELECTROLYTE AND ELECTROCHROMIC DEVICE CONTAINING SAME | LG CHEMICAL LTD (KR) | 2022-02-09 | — | — | EP | disclosed |
| US-20120205234-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | SHOWA DENKO K.K. (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20110137066-A1 | PROCESS OF INHIBITING POLYMERIZATION OF ISOCYANATE GROUP-CONTAINING, ETHYLENICALLY UNSATURATED CARBOXYLATE COMPOUNDS, AND PROCESS FOR PRODUCING THE COMPOUNDS | SHOWA DENKO K.K. (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2325166-A1 | METHOD FOR INHIBITING POLYMERIZATION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTER COMPOUND CONTAINING ISOCYANATE GROUP AND METHOD FOR PRODUCING ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTER COMPOUND CONTAINING ISOCYANATE GROUP | Showa Denko K.K. (JP) | 2011-05-25 | — | — | EP | disclosed |
| US-20100099827-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | SHOWA DENKO K.K. (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2091994-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | Showa Denko K.K. (JP) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008069256-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | SHOWA DENKO K.K. (JP) | 2008-06-12 | — | — | WO | disclosed |
| EP-1713787-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2006-10-25 | — | — | EP | disclosed |
| WO-2005075445-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
| EP-0586268-B1 | A pathogenic substance removing material and a blood filter comprising said material | TERUMO CORP (JP) | 2000-02-23 | — | — | EP | disclosed |
| EP-0586268-A1 | A pathogenic substance removing material and a blood filter comprising said material | TERUMO KABUSHIKI KAISHA (JP) | 1994-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11661474-B2 | Composition, production method for composition, and production method for unsaturated compound | ELOVL1, ACOX1, NCOA1 | TSHR 3345/4885ALDH1A1 1279/4885TP53 4827/4885 |
| US-20110137066-A1 | PROCESS OF INHIBITING POLYMERIZATION OF ISOCYANATE GROUP-CONTAINING, ETHYLENICALLY UNSATURATED CARBOXYLATE COMPOUNDS, AND PROCESS FOR PRODUCING THE COMPOUNDS | ALKBH3, OGDH, IDH2 | TSHR 4884/4885ALDH1A1 189/4885TP53 4083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.